期刊文献+

恶性脑膜瘤的诊断及治疗(附16例分析) 被引量:1

Diagnosis and treatment of malignant meningioma(a report of 16 cases)
下载PDF
导出
摘要 目的探讨恶性(WHOⅢ级)脑膜瘤的诊断及治疗方法。方法回顾性分析16例WHOⅢ级脑膜瘤患者的临床资料。结果本组患者临床表现主要为头痛、头晕等高颅内压症状。MRI或CT表现主要为肿瘤分叶、不均匀强化、边界不清、瘤周水肿重,少数有脑膜尾征等。16例患者共行30次显微手术。病理类型为间变型10例,横纹肌样型2例,乳头状型2例,砂粒体型术后恶变2例。手术切除分级为SimpsonⅠ级7例、Ⅱ级8例、Ⅳ级1例,手术切除分级与肿瘤部位、是否复发、瘤周水肿程度、基底宽窄、术中出血量有关(P均<0.05),而与病理类型、Ki-67值、肿瘤大小无关。14例患者完成随访,术后1年,肿瘤复发6例、死亡3例;术后3年,肿瘤复发11例、死亡8例;术后5年,肿瘤复发11例、死亡10例;术后10年,肿瘤复发13例、死亡11例。结论恶性脑膜瘤临床表现无特异性,MRI或CT检查有助于术前诊断,确诊主要依靠病理诊断,治疗首选显微手术切除,预后较差。 Objective To investigate the diagnosis and treatment of malignant( WHO grade Ⅲ) meningiomas.Method The clinical data of 16 cases of patients with WHO grade Ⅲ meningioma were retrospectively analyzed. Results The clinical manifestations of the patients were the high intracranial pressure symptoms such as headache,dizziness and so on. MRI or CT mainly showed that the tumor shape was irregular,the enhancement was inhomogeneous,the boundary was unclear,the peritumoral edema was heavy and some had the dural tail sign. A total of 16 patients underwent microsurgery for 30 times. The pathologic types: 10 cases of anaplastic type,2 cases of rhabdoid type,2 cases of papillary type and2 cases of postoperative malignant psammomatous. Surgical resection grade Simpson 1 level was found in 7 cases,8 cases of grade II and 1 case of grade Ⅳ. The surgical resection grade was related with the tumor location,whether recurrence,degree of peritumoral edema,basal width and the amount of bleeding( all P〈0. 05),but was not related with the pathological type,Ki-67 values and tumor size. Fourteen patients were followed up,one year after surgery,6 cases recurred and 3cases died; three years after sergery,11 cases had tumor recurrence and 8 cases died; five years after surgery,11 cases had tumor recurrence and 10 cases died; ten years after surgery,13 cases had tumor recurrence and 11 cases died. Conclusions The clinical manifestations of malignant meningioma are not specific. MRI or CT examination is helpful for preoperative diagnosis,and the diagnosis mainly depends on the pathological diagnosis. The microsurgical resection treatment is the first choice,but the prognosis is poor.
出处 《山东医药》 CAS 北大核心 2015年第47期41-43,共3页 Shandong Medical Journal
基金 四川省重点科技支撑项目(2013SZZ002)
关键词 中枢神经系统肿瘤 脑膜瘤 手术切除分级 central nervous system neoplasms meningioma surgical resection grade
  • 相关文献

参考文献14

  • 1Choy W,Kim W,Nagasawa D,et al.The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments[J].Neurosurg Focus,2011,30(5):E6.
  • 2Baek BJ,Shin JM,Lee CK,et al.Atypical primary meningioma in the nasal septum with malignant transformation and distant metastasis[J].BMC Cancer,2012,12:275.
  • 3Liu L,Yin B,Geng DY,et al.Comparison of ADC values of intracranial hemangiopericytomas and angiomatous and anaplastic meningiomas[J].J Neuroradiol,2014,41(3):188-194.
  • 4蒋洪涛,张健,费昶,衡雪源.恶性脑膜瘤17例临床分析[J].山东医药,2009,49(38):46-47. 被引量:2
  • 5Zhao P,Hu M,Zhao M,et al.Prognostic factors for patients with atypical or malignant meningiomas treated at a single center[J].Neurosurg Rev,2015,38(1):101-107.
  • 6Alexiou GA,Vartholomatos G,Goussia A,et al.Fast cell cycle analysis for intraoperative characterization of brain tumor margins and malignancy[J].J Clin Neurosci,2015,22(1):129-132.
  • 7Kaur G,Sayegh ET,Larson A,et al.Adjuvant radiotherapy for atypical and malignant meningiomas:a systematic review[J].Neuro Oncol,2014,16(5):628-636.
  • 8Yamaguchi S,Terasaka S,Kobayashi H,et al.Prognostic factors for survival in patients with high-grade meningioma and recurrencerisk stratification for application of radiotherapy[J].PLo S One,2014,9(5):e97108.
  • 9Ferraro DJ,Funk RK,Blackett JW,et al.A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas[J].Radiat Oncol,2014,9:38.
  • 10Aghi MK,Carter BS,Cosgrove GR,et al.Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation[J].Neurosurgery,2009,64(1):56-60.

二级参考文献9

  • 1Kleihues P,Louis DN,Scheithauer BW,et al. The WHO classification of tumors of the nervous system [J]. J Neuropathol Exp Neurol ,2002,61 (3) :215-225.
  • 2Perry A,Scheithauer BW,Stafford SL,et al. " Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications [J]. Cancer,1999,85(9) :2046-2056.
  • 3Whittle IR, Smith C, Navoo P, et al. Meningiomas [ J ]. Lancet, 2004,363 ( 9420 ) : 1535-1543.
  • 4Mahmood A, Caccamo DV, Tomecek FJ. Atypical and malignant meningiomas : a clinicopathological review [ J ]. N eurosurgery, 1993, 33(6) :955-963.
  • 5Nakasu S, Nakajima M, Matsumura K, et al. Meningioma: proliferating potential and clinlcoradiological features [J]. Neurosurgery, 1995,37(6) :1049-1055.
  • 6Mattei TA, Mattei JA, Ramina R,et al. Edema and malignancy in meningiomas [J]. Clinics ,2005,60 (7) :201-206.
  • 7Smith HP, Challa VR, Moody DM, et al. Biological features of meningiomas that determine the production of cerebral edema [ J ]. 1981 ,Neurosurgery,8(4) :428-433.
  • 8Black PM,Villavicencio AT, Rhouddou C, et al. Aggressive surgery and focal radiation in the management of meningiomas of the skull base:preservation of function with maintenance of local control [J]. Acta Neurochir(Wicn) ,2001,143 (6) :555-562.
  • 9Roberti F, Sekhar LN, Kalavakonda C, et al. Posterior fossa meningiomas : surgical experience in 161 cases [J]. Surg Neurol, 2001,56 (1) :8-20.

共引文献1

同被引文献19

  • 1Scheitzach J, Schebesch KM, Brawanski A,et al. Skull base meningiomas neurological outcome after Microsurgical re- section [J]. J Neurooncol, 2014,116 (2) : 381-386.
  • 2Jin Y, Xiong A,Zhang Z, et al. MicroRNA-31 suppresses medulloblastoma cell growth by inhibiting DNA replica- tion through minichromosome maintenance 2 [J]. Oncotar- get, 2014,5 (13) : 4821-4833.
  • 3Noguchi S,Mori T, Otsuka Y, et al. Anti-oncogenic mi- croRNA-203 induces senescence by targeting E2F3 pro- tein in human melanoma cells [J]. J Biol Chem.,2012,287 (15) : 11769-11777.
  • 4Suzuki T,Yasui W,Yokozaki H,et al.Expression of the E2F family in human gastrointestinal carcinomas [J]. Int J Cancer, 1999,81(4) : 535-538.
  • 5Hua C,Zhao G, Li Y, et al. Minichromosome Maintenance (MCM)Family aspotential diagnostic and prognostic tumormarkers for human gliomas [J]. BMC Cancer,2014,14(30) : 526.
  • 6Liu M,Li JS,Tian DP,et al. MCM2 expression levels pre- dict diagnosis and prognosis in gastric cardiaecancer [J]. Histol Histooathol, 2013,28 (4) : 481-492.
  • 7Saydam 0, Senol O, Sehaaij -Visser TB, et al. Compara- tive protein profiling reveals minichromosome mainte- nance (MCM) proteins as novel potential tumor markers for meningiomas [J]. J Proteome Res,2010,9 (1):485- 494.
  • 8Sears RC, Nevins JR. Signaling networks that link cell proliferation and cell fate [J]. J Biol Chem,2002,277(14) : 11617-11620.
  • 9Liu Y,He G,Wang Y,et ak MCM-2 is a therapeutic target of Trichostatin A in colon cancer cells [J]. Toxicol- ogy lett, 2013,221 ( 1 ) : 23-30.
  • 10Lee JM,Heo MJ,Lee CG,et al. Increase of miR-199a-5p by protoporphyrin IX , a photocatalyzer,directly inhibits E2F3, sensitizing mesenchymal tumor cells to anti-can- cer agents [J]. Oncotarget,2015,6(6):3918-3931.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部